Delisting risk
IGC Pharma
Develops an investigational oral THC-and-melatonin therapy for Alzheimer’s-dementia agitation.
$0.3107
After-hours close+0.00 (+1.04%)
At close$0.3075(−7.91%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 4.33%Insiders —
Shares outstanding 100.09M · Float 86.08M · 86.0% free float
Institutions13F, as of Mar 31, 2026
35 holders · 4.33M shares · 11 new positions · 17 increased · 5 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 1.04M | 1.04% | +182.9K | May 15, 2026 |
| Vanguard Capital Management LLC | 718.4K | 0.72% | +718.4Knew | May 15, 2026 |
| BlackRock, Inc. | 703.8K | 0.70% | 0 | May 13, 2026 |
| Renaissance Technologies LLC | 484.0K | 0.48% | −435.7K | May 14, 2026 |
| Vanguard Fiduciary Trust Co | 415.9K | 0.42% | +415.9Knew | May 8, 2026 |
| State Street Corp | 200.8K | 0.20% | 0 | May 15, 2026 |
| Susquehanna International Group, LLP | 122.6K | 0.12% | −32.4K | May 15, 2026 |
| Northern Trust Corp | 113.4K | 0.11% | 0 | May 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.